LACDR

Universiteit Leiden

List
Filter

Found 12 results. Export: Tagged | XML

Filters: keyword is Gly [Clear All Filters]

2008

Groenendaal, D., Freijer, J., Rosier, A., de Mik, D., Nicholls, G., Hersey, A., Ayrton, A.D., Danhof, M., de Lange, E.C. , Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics, Eur J Pharm Sci, vol. 34, no. 2-3, pp. 149-63.

Post, T.M., Freijer, J. I, Ploeger, B.A., Danhof, M. , Extensions to the visual predictive check to facilitate model performance evaluation, J Pharmacokinet Pharmacodyn, vol. 35, no. 2, pp. 185-202.

2006

de Winter, W., DeJongh, J., Post, T., Ploeger, B., Urquhart, R., Moules, I, Eckland, D., Danhof, M. , A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus, J Pharmacokinet Pharmacodyn, vol. 33, no. 3, pp. 313-43.

2005

Visser, C.C., Stevanovic, S., Voorwinden, L.H., van Bloois, L., Gaillard, P.J., Danhof, M., Crommelin, D.J., de Boer, A.G. , Targeting liposomes with protein drugs to the blood-brain barrier in vitro, Eur J Pharm Sci, vol. 25, no. 2-3, pp. 299-305.

2001

Li, G.L., Danhof, M., Bouwstra, J.A. , Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro, Pharm Res, vol. 18, no. 11, pp. 1627-30.

1997

van Schaick, E.A., de Greef, H.J., Ijzerman, A.P., Danhof, M. , Physiological indirect effect modeling of the antilipolytic effects of adenosine A1-receptor agonists, J Pharmacokinet Biopharm, vol. 25, no. 6, pp. 673-94.

1992

Danhof, M., de Boer, A., Magnani, H.N., Stiekema, J.C. , Pharmacokinetic considerations on Orgaran (Org 10172) therapy, Haemostasis, vol. 22, no. 2, pp. 73-84.

1991

de Boer, A., Stiekema, J.C., Danhof, M., van Dinther, T.G., Boeijinga, J.K., Cohen, A.F., Breimer, D.D. , Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers, Antimicrob Agents Chemother, vol. 35, no. 10, pp. 2110-5.

de Boer, A., Stiekema, J.C., Danhof, M., Breimer, D.D. , Influence of chlorthalidone on the pharmacokinetics and pharmacodynamics of Org 10172 (Lomoparan), a low molecular weight heparinoid, in healthy volunteers, J Clin Pharmacol, vol. 31, no. 7, pp. 611-7.

De Boer, A., Stiekema, J.C., Danhof, M., Breimer, D.D. , The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172, Br J Clin Pharmacol, vol. 32, no. 1, pp. 23-9.

de Boer, A., Danhof, M., Cohen, A.F., Magnani, H.N., Breimer, D.D. , Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers, Thromb Haemost, vol. 66, no. 2, pp. 202-7.

1990

Stiekema, J.C., de Boer, A., Danhof, M., Kroon, C., Broekmans, A.W., van Dinther, T.G., Voerman, J., Breimer, D.D. , Interaction of the combined medication with the new low-molecular-weight heparinoid Lomoparan (Org 10172) and acenocoumarol, Haemostasis, vol. 20, no. 3, pp. 136-46.

LACDR